The pharmacokinetics, pharmacodynamics and tolerability of PUR0200, a novel tiotropium formulation, in chronic obstructive pulmonary disease

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

(2017) Simon D Harding et al.   NUCLEIC ACIDS RESEARCH

Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study

(2017) Dave Singh et al.   International Journal of Chronic Obstructive Pulmonary Disease

Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease

(2016) Dave Singh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study

(2016) Dave Singh et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD

(2016) Andre-Bernard Tonnel   International Journal of Chronic Obstructive Pulmonary Disease

Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease

(2015) Brian R. Leaker et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?

(2015) Nicola Scichilone et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Validation of a General In Vitro Approach for Prediction of Total Lung Deposition in Healthy Adults for Pharmaceutical Inhalation Products

(2013) Bo Olsson et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis

(2012) Diana Bilton et al.   Journal of Cystic Fibrosis

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

(2011) Claus Vogelmeier et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biochemical properties, pharmacokinetics and pharmacological response of tiotropium in chronic obstructive pulmonary disease patients

(2009) David Price et al.   Expert Opinion on Drug Metabolism & Toxicology

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

(2008) Donald P. Tashkin et al.   NEW ENGLAND JOURNAL OF MEDICINE